The study and its comparison
A blinded trial randomized 110 people with peripheral artery disease to foods containing thirty grams of milled flaxseed daily or placebo foods for six months. [1]
At follow-up, systolic and diastolic pressure were approximately ten and seven millimeters of mercury lower in the flaxseed group. Body weight did not significantly differ. Changes in selected circulating fatty-acid and lignan measures correlated with pressure changes. [1]
What the finding establishes
Those correlations cannot identify which seed constituent caused the result. Fiber, lignans and fat were delivered together, so the findings cannot be transferred directly to oil or an oil–vitamin D combination. Funding and conflicts were not established from the abstract. Blood-pressure effects in this selected vascular-disease group do not establish fewer strokes or universal benefit. [1]
A hypothetical distinction
Imagine the whole food contains several active constituents. An oil-only capsule does not reproduce that intervention.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Potent antihypertensive action of dietary flaxseed in hypertensive patients.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.